Raymond James & Associates Establishment Labs Holdings Inc. Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$41.46 - $59.86 $188,477 - $272,123	4,546 New	4,546 $206,000
Q4 2022 Feb 08, 2023	SELL	$51.0 - $72.94 $4,743 - $6,783	-93 Reduced 2.14%	4,250 $279,000
Q1 2022 May 11, 2022	BUY	$48.73 - $69.9 $4,531 - $6,500	93 Added 2.19%	4,343 $293,000
Q4 2021 Feb 08, 2022	SELL	$59.19 - $81.54 $1,420 - $1,956	-24 Reduced 0.56%	4,250 $287,000
Q3 2021 Nov 02, 2021	BUY	$65.48 - $88.21 $1,571 - $2,117	24 Added 0.56%	4,274 $306,000
Q1 2021 May 14, 2021	BUY	$36.0 - $73.76 $153,000 - $313,480	4,250 New	4,250 $266,000

148

24.5M

292K

352K

Ticker ESTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,268,500
Market Cap $1.12B
Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.